3-O-Arylmethylgalangin, a novel isostere for anti-HCV 1,3-diketoacids (DKAs) (Q39648993)

13 September 2017

title

3-O-Arylmethylgalangin, a novel isostere for anti-HCV 1,3-diketoacids (DKAs) (English)

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

25 July 2024

2

Kwang-Su Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888241

25 July 2024

4

Dong-Eun Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888241

25 July 2024

author name string

Hyo Seon Lee

1

1 reference

13 September 2017

Bokhui Lee

3

1 reference

13 September 2017

Youhoon Chong

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

16 September 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0968089610008485?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

https://api.elsevier.com/content/article/PII:S0968089610008485?httpAccept=text/plain

25 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Bioorganic & Medicinal Chemistry

25 July 2024

published in

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

21

1 reference

13 September 2017

page(s)

7331-7337

1 reference

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

25 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species

25 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors

25 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

25 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells

25 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase

25 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques

25 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

25 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors

25 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase

25 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues

25 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation

25 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Role of flavonoids and iron chelation in antioxidant action

25 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

The antioxidant properties of theaflavins and their gallate esters--radical scavengers or metal chelators?

25 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Synthesis and biological activities of 8-arylflavones

25 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

25 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

25 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.

25 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System

25 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.09.021

25 July 2024

Identifiers

1 reference

13 September 2017

1 reference